Gestational diabetes mellitus: does an effective prevention strategy exist?

Abstract

The overall incidence of gestational diabetes mellitus (GDM) is increasing worldwide. Preventing pathological hyperglycaemia during pregnancy could have several benefits: a reduction in the immediate adverse outcomes during pregnancy, a reduced risk of long-term sequelae and a decrease in the economic burden to healthcare systems. In this Review we examine the evidence supporting lifestyle modification strategies in women with and without risk factors for GDM, and the efficacy of dietary supplementation and pharmacological approaches to prevent this disease. A high degree of heterogeneity exists between trials so a generalised recommendation is problematic. In population studies of dietary or combined lifestyle measures, risk of developing GDM is not improved and those involving a physical activity intervention have yielded conflicting results. In pregnant women with obesity, dietary modification might reduce fetal macrosomia but in these patients, low compliance and no significant reduction in the incidence of GDM has been observed in trials investigating physical activity. Supplementation with probiotics or myoinositol have reduced the incidence of GDM but confirmatory studies are still needed. In randomized controlled trials, metformin does not prevent GDM in certain at-risk groups. Given the considerable potential for reducing disease burden, further research is needed to identify strategies that can be easily and effectively implemented on a population level.

• Authors: Rochan Agha-Jaffar, Nick Oliver, Desmond Johnston, Stephen Robinson
• Journal: Nature reviews. Endocrinology (Nat Rev Endocrinol) Vol. 12 Issue 9 Pg. 533-46 (09 2016) ISSN: 1759-5037 [Electronic] England
• PMID: 27339886 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)

Chemical References

• Metformin

Topics

• Diabetes, Gestational (metabolism, prevention & control, therapy)
• Dietary Supplements
• Exercise (physiology)
• Female
• Fetal Development (drug effects, physiology)
• Humans
• Insulin Resistance (physiology)
• Metformin (therapeutic use)
• Pregnancy
• Probiotics (therapeutic use)
• Risk Reduction Behavior